Biolevate
French tech company | Builders Republic
About
AI-assisted writing platform that helps pharma, biotech and academic life-science teams produce and manage regulatory and scientific documents — its ELISE engine extracts and structures information from research papers, experimental data and unstructured content, automates literature synthesis and compliance checks, and drafts medical-writing deliverables.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2023
- City
- SUCY-EN-BRIE
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 6.0 M€ raised since 2020
Funding rounds
- Series A — 2024
Investors
- bpifrance
- EQT Ventures